⬤ IRS-Compliant Valuations

409A Valuation for Israeli Companies

If your Israeli company has executed a Delaware Flip, grants stock options under Section 102, or raises capital from U.S. investors, a defensible 409A valuation is mandatory under IRS rules.

409A Valuation Services for Israeli Startups & Tech Companies

Israel’s reputation as the Startup Nation is built on a relentless pipeline of world-class technology companies. Most of them, by design, are deeply intertwined with the U.S. capital markets from day one. Whether you operate as a standalone Israeli company granting Section 102 options, or you have flipped to a Delaware C-Corp parent with an Israeli R&D subsidiary, your equity compliance now spans two demanding tax regimes.

If your company issues stock options to U.S. employees, raises capital from American venture capitalists, or operates under a U.S. parent entity, the IRS requires a reliable 409A valuation. Navigating this requirement alongside Israeli rules under the Income Tax Ordinance demands specialized expertise. Errors in valuation, particularly around Section 102 trustee tracks, share class structures, and currency conversions, can result in severe tax penalties for both your company and your team.

This guide provides Israeli founders, CFOs, and finance leaders with clear, actionable steps to manage U.S. tax obligations effectively. We will cover:

How Section 102 of the Israeli Income Tax Ordinance interacts with U.S. IRS requirements.
Why a Delaware Flip changes your equity compliance overnight.
The unique complexities of cross-border valuations for Israeli startups.
Best practices for maintaining full compliance for your equity incentive plans.

What is a 409A Valuation? (Israeli Perspective)

A 409A valuation determines the fair market value (FMV) of your company’s common shares. The IRS requires this appraisal under Section 409A of the Internal Revenue Code to ensure private companies do not issue stock options at a discount to U.S. taxpayers.

For Israeli founders, the closest local comparison is the valuation work required to set the exercise price for stock options granted under Section 102 of the Income Tax Ordinance. Israeli law offers two main tracks: the Capital Gains Route through a trustee (with a 2-year holding period) and the Ordinary Income Route. Both require fair market value pricing, but the Israel Tax Authority and the IRS apply different valuation frameworks, with the IRS imposing significantly stricter penalties for non-compliance.

A 409A valuation bridges the gap between your Israeli company and the U.S. market, ensuring full compliance with IRS regulations and protecting your U.S.-based employees from immediate taxation and a 20% federal penalty on vested options.

Get Your Free 30-Minute Consultation Today

Ensure your business stays compliant and ahead of the curve with reliable 409A valuations from our expert team. Schedule your free 30-minute consultation now to discuss your needs, understand the process, and receive guidance tailored to your company’s unique situation.

When Dos Israeli Companies Need a 409A Valuation?

Many Israeli founders assume U.S. tax laws only apply once they have fully relocated their headquarters. That simply is not true. Below are the most common scenarios that trigger a 409A requirement for Israeli businesses.

Israeli Startups After a Delaware Flip

The Delaware Flip is the default structure for most VC-backed Israeli startups. A new U.S. Delaware C-Corp becomes the parent entity, while the original Israeli company becomes a wholly-owned R&D subsidiary. This structure is often a prerequisite for raising significant U.S. venture capital and accessing American customers. Once you flip, all equity issued from the U.S. parent must comply with IRS Section 409A. Your previous Israeli valuation, even if performed for Section 102 purposes, is no longer sufficient. Failing to obtain a U.S.-compliant 409A valuation puts every subsequent option grant at risk.

Section 102 Plans Issued by an Israeli Parent with U.S. Employees

If your company is still structured as an Israeli parent and you grant Section 102 options to employees who happen to be U.S. citizens, U.S. green card holders, or U.S. tax residents, you have triggered Section 409A. The IRS treats those individuals as U.S. taxpayers regardless of where the issuing entity sits. Failure to price these options at FMV under U.S. rules results in immediate income recognition for your U.S. employees on vested options, plus an additional 20% federal penalty tax. This destroys the incentive value of your equity plan and damages employee trust.

Israeli Companies Raising U.S. Capital

U.S. venture capital firms expect rigorous financial compliance before they wire funds. American investors will heavily scrutinize your cap table during due diligence, especially if any options have been granted to U.S. taxpayers. Having an updated, auditor-backed 409A valuation proves your equity house is in order and prevents funding delays or last-minute valuation disputes.

Secondary Transactions and Tender Offers

Israeli startups frequently run secondary transactions where early employees or angel investors sell shares to incoming VCs. When any party to the transaction is a U.S. taxpayer, you must prove the shares were transferred at fair market value. A defensible 409A valuation protects all parties from future IRS disputes and establishes a clear audit trail.

Managing Section 102 and IRS 409A Requirements Simultaneously

One of the most underestimated challenges for Israeli founders is the tension between maintaining Section 102 benefits for Israeli employees and complying with U.S. equity rules for U.S.-based team members and investors.

Section 102, particularly the Capital Gains Route through a trustee, offers significant Israeli tax advantages for employees, including a 25% capital gains rate on the appreciation portion of options held for the mandatory 2-year period. Losing access to this preferential treatment, often through poorly structured grants or non-compliant valuations, materially impacts employee net outcomes at exit.
At the same time, granting equity from a Delaware C-Corp parent to U.S. employees creates direct IRS exposure. Founders often need to run dual equity plans: Section 102 grants for the Israeli subsidiary’s employees and 409A-compliant grants from the U.S. parent for American team members. A well-executed 409A valuation accounts for these dual obligations, ensuring you neither compromise Israeli tax positions nor expose U.S. employees to penalty taxation.

At the same time, granting equity to U.S. employees from a Canadian entity creates direct IRS exposure. Founders must navigate both regimes simultaneously. A well-executed 409A valuation accounts for these dual obligations, ensuring you neither compromise Canadian tax positions nor expose U.S. employees to penalty taxation.

Cross-Border Valuation Complexities for Israeli Startups

Valuing a cross-border Israeli company is significantly harder than valuing a standard U.S. startup.Founders face several unique complications:

Currency Conversion

Your Israeli entity reports in NIS (New Israeli Shekel), but U.S. investors and the IRS require USD figures. Accurate currency conversion at the appropriate valuation date materially impacts your reported FMV, particularly given recent ILS volatility.

Accounting Standards Differences

Israeli companies typically file under IFRS, while U.S. valuations rely on GAAP. Translating financial statements between these frameworks requires professional judgment, particularly around revenue recognition, R&D capitalization, and stock-based compensation expense.

R&D Center Cost Allocation

Most Delaware-flipped Israeli structures operate the Israeli subsidiary as a cost-plus R&D center for the U.S. parent. Transfer pricing arrangements, Office of the Chief Scientist (Innovation Authority) grants, and intercompany agreements all influence the valuation in ways generic U.S. valuators may miss.

Comparable Company Selection

Finding appropriate U.S.-listed comparables for an Israeli cybersecurity, fintech, or AI startup requires sector-specific knowledge of both markets, especially when the company has unique features tied to its TASE-listed peers, defense-industry origins, or Israel-specific regulatory exposure.

Why Choose CountSure Over Automated Software-Based 409A Providers?

Automated cap table platforms have made valuations faster and more accessible for simple, early-stage, U.S.-only startups. That is genuinely good for the ecosystem. But the moment you add Israeli complexity, automation alone creates massive compliance risks. Here is why cross-border companies require human experts.

Feature	Automated Software Providers	CountSure (Expert-Led)
Handling Complexity	Struggle with NIS-USD conversions and IFRS-to-GAAP translations. Cannot apply professional judgment to dual-jurisdiction Israeli structures or Section 102 implications.	CPAs and Chartered Accountants understand both Israeli and U.S. standards, accurately managing Section 102 trustee tracks, R&D center transfer pricing, and Delaware Flip complications.
Safe Harbor Status	Reliance on templates can fail IRS independence requirements, risking the loss of safe harbor protection for your company.	Every valuation is conducted by a qualified independent appraiser, ensuring the methodology is sound and defensible for safe harbor status.
Auditor Acceptance	Reports often face scrutiny from auditors due to thin documentation and lack of company-specific analysis, leading to pushback from Big Four reviewers.	100% auditor acceptance rate. Every report is built to withstand the rigorous scrutiny of Big Four firms in both Israel and the U.S.
Data Accuracy	The accuracy of the output depends entirely on the user's input. The system cannot identify errors in uploaded data, including Innovation Authority grant treatment.	Our process includes a dedicated analyst review of your financials and equity structure to verify data accuracy before the valuation begins.
Client Relationship	Each valuation is treated as a one-off transaction. There is no long-term relationship or institutional knowledge of your business.	We build long-term partnerships. Your dedicated analyst understands your company's history and is available to answer questions from your team, board, and investors.

Ready to Simplify Your 409A Valuation?

Let’s talk about how we can help your firm scale smarter.

How CountSure Supports Israeli Companies

CountSure provides fast, IRS-compliant 409A valuation services specifically designed for growing Israeli startups. Our team of over 20 professionals includes CPAs (US), Chartered Accountants, and IBBI Registered Valuers who understand both U.S. and Israeli accounting standards, as well as the practical realities of cross-border equity structures.

Fast, Audit-Ready Reports

Receive your 409A valuation report in just 9–12 days, ensuring you never miss a hiring deadline or financing close. Using certified professionals, such as CPAs and Chartered Accountants, guarantees IRS safe harbor protection. Expert appraisers understand how to weigh qualitative factors alongside quantitative data, delivering a defensible report that software simply cannot replicate.

Transparent, Fixed-Fee Pricing

Our straightforward pricing model means you know the full cost upfront in NIS or USD, with no surprise fees.

100% Auditor Acceptance Rate

Issue equity with complete confidence, knowing our valuations meet rigorous audit standards on both sides of the border.

Partner With CountSure for Your Cross-Border Valuation

Parth Shah, Managing Director

(CPA-US, FCA, RV-S&FA, DISA)

Securing a reliable 409A valuation service for your Israeli company does not have to be stressful. You need a partner who understands the nuances of cross-border growth, respects your timeline, and guarantees auditor acceptance. CountSure’s expert team is ready to help you navigate IRS compliance with ease, whether you remain an Israeli parent issuing Section 102 grants or have flipped to Delaware.

Talk to our team today to schedule a free consultation. We will review your cap table, discuss your unique jurisdictional challenges, and provide a clear, fixed-fee path forward.

Conclusion

You now have everything you need to handle your 409A valuation requirements properly. The penalties for non-compliance are severe, with U.S. employees facing up to 40% in additional taxes, so this is not something to postpone or handle casually.

Take action before issuing your first stock options to U.S. employees, refresh your valuation after funding rounds or Delaware Flips, and stay on top of annual updates. Choose a qualified provider who can defend your valuation if questioned by the IRS, your auditors, or future investors. By the same token, remember that audit defensibility matters far more than saving a few thousand dollars upfront.

Common Questions

Frequently Asked Questions

Q1. Can I use an automated software provider for my Israeli startup?

If your company has any cross-border complexity, such as a Delaware Flip, U.S. employees, Section 102 grants, or significant Innovation Authority funding, automated software typically falls short. You need human CPAs and CAs to handle IFRS-to-GAAP conversions, NIS-USD adjustments, and Section 102 implications accurately.

Q2. How often does my Israeli company need a 409A refresh?

The IRS requires a new valuation every 12 months. You also need a refresh after any material event, such as closing a new funding round, executing a Delaware Flip, completing a major acquisition, or experiencing a significant business pivot.

Q3. What happens if we grant options to U.S. employees without a 409A?

You risk severe IRS penalties. Your U.S. employees could face immediate income tax on their vested options, plus an additional 20% federal penalty tax. This effectively destroys the incentive value of your equity plan and exposes your company to potential withholding obligations.

Q4. Can the same valuation report be used for Section 102 and 409A?

In most cases, no. While both regimes require fair market value, the methodologies, documentation standards, and audit defensibility requirements differ. We typically prepare a 409A-compliant report that can serve as supporting evidence for Section 102 purposes, but the report itself is engineered to U.S. IRS standards.

Q5. How much does a 409A valuation cost for a cross-border Israeli company?

Pricing typically ranges from $1,500 to $15,000 USD depending on your company’s stage and cap table complexity. We offer transparent, fixed-fee pricing upfront so there are no surprises.

Q6. How long does the valuation process take?

Once we receive your financial data, cap table, and any relevant Delaware Flip or Section 102 documentation, CountSure delivers your completed, audit-ready valuation report in just 9 to 12 days.